BLOG
    FAQ
    X
    Visit blog page
    LATISSE® 5ml  distributors
    LATISSE® 5ml  distributors
    LATISSE® 5ml  distributors
    LATISSE® 5ml  distributors

    Buy LATISSE® 5ml Online

    (0)

    0

    brand:

    LATISSE®

    manufacturer:

    Allergan

    active substances:

    BIMATOPROST

    strength:

    0.3mg/ml

    pack size:

    5ml in a 5ml bottle with 140 applicators

    INFORMATION

    Product Description

    LATISSE® Product Overview

    LATISSE®  is a prescription treatment developed for hypotrichosis of the eyelashes, a condition characterized by inadequate lash growth. LATISSE® works as a prostaglandin analog, promoting longer, thicker, and darker eyelashes. Administered via a nightly application on the upper eyelid margin, it is generally well-tolerated, providing visible results within 8-16 weeks.

    Key Features:

    • Active Ingredient: Bimatoprost 0.3 mg/mL
    • Application: Once nightly on the upper eyelid margin
    • Primary Action: Increases lash growth in terms of length, thickness, and darkness
    • Pack Size: 5ml in a 5ml bottle with 140 applicators

    LATISSE® Indications for Use

    LATISSE® is indicated for eyelash hypotrichosis treatment, specifically enhancing the length, thickness, and pigmentation of lashes. Patients often observe noticeable improvements by the end of a 16-week treatment cycle.

    Primary Indications:

    • Eyelash Growth: Increases the length, density, and darkness of eyelashes for those experiencing thin or sparse lash growth.

    LATISSE® Dosage Information

    LATISSE® is intended for nightly application using sterile applicators included in the package. Application on the lower lid is not advised due to potential unintended hair growth on nearby areas.

    Application Protocol:

    • Dosage: Apply one drop of LATISSE® on the sterile applicator, applying it along the upper eyelid margin at the base of the lashes.
    • Frequency: Once nightly; additional applications do not enhance results.
    • Precautions: Remove makeup and contact lenses before application. Blot any excess product outside the lash line with a tissue.

    Expected Outcomes:

    • Onset of Results: Visible growth improvement typically begins after 8 weeks, with full effects around 16 weeks.
    • Post-Treatment Changes: If treatment is discontinued, lashes gradually return to their baseline appearance over several weeks to months.

    LATISSE® Side Effects and Precautions

    LATISSE® has a favorable safety profile but may lead to mild side effects in some patients. Notable precautions are advised for those using intraocular pressure-lowering agents, as LATISSE® may reduce their effectiveness.

    Common Side Effects:

    • Eye Itching or Redness: Reported in about 4% of patients.
    • Skin Pigmentation: Darkening of the upper eyelid skin, which may be reversible upon discontinuation.
    • Eye Dryness or Irritation: Occasional reports of ocular discomfort or dryness.

    Warnings and Precautions:

    • Intraocular Pressure (IOP) Concerns: Patients using intraocular pressure-lowering agents should consult with their physician before use, as LATISSE® may interfere with desired IOP reduction.
    • Iris Pigmentation: Increased pigmentation of the iris (brown coloring) may occur, which is typically irreversible.
    • Periorbital Hair Growth: LATISSE® should be applied only to the upper eyelid margin, as excess application may result in hair growth in unintended areas.
    • Handling Precautions: Use a new applicator for each eyelid to avoid contamination, which can lead to infections.

    LATISSE® Clinical Studies or Real-World Outcomes

    Clinical trials for LATISSE® demonstrate significant efficacy, with patients observing longer, thicker, and darker lashes by week 16.

    Study Findings:

    • Eyelash Prominence: 78% of LATISSE® users reported a one-grade increase in overall lash prominence by week 16, compared to 18% of the control group.
    • Measurement Outcomes: On average, eyelash length increased by 25%, thickness by 106%, and darkness by 18%.
    • Patient Satisfaction: High satisfaction due to improvements in lash appearance, with minimal side effects in the majority of patients.

    Clinical Observations:

    • Efficacy in Adolescents: LATISSE® has also shown safe use in teenagers with hypotrichosis, providing similar efficacy to adults.
    • Gradual Effect Reversal: After the 16-week application cycle, effects diminish over time if treatment is stopped, reverting to the baseline lash appearance.

    LATISSE®  Composition and Active Ingredients

    LATISSE® contains bimatoprost 0.3 mg/mL as its active ingredient, supported by other compounds that stabilize the solution for safe, effective use on delicate eye tissues.

    Key Ingredients:

    • Bimatoprost: A prostaglandin analog that extends the anagen (growth) phase of eyelash hair cycles.
    • Benzalkonium Chloride: A preservative; contact lenses should be removed before application and reinserted 15 minutes later to prevent lens discoloration.

    LATISSE® Drug Interactions

    While LATISSE® has minimal systemic absorption, precautions are necessary for patients using medications that may interact with prostaglandin analogs.

    Important Considerations:

    • Concurrent Use with Prostaglandin Analogs: Patients using other prostaglandin analogs for IOP management should consult their physician, as LATISSE® may reduce the effectiveness of these medications.
    • Intraocular Anti-Inflammatories: LATISSE® should be used cautiously in patients with active intraocular inflammation due to potential exacerbation.

    Related Products
    Shopping Bag0
    There are no products in the cart!